explore -WSS

explore

author：leisure time 2025-09-27 23:52:47 - browse：88

Each COVID-19 vaccine vial from various companies is placed on individual rectangular backgrounds. Pfizer-BioNTech is positioned in the middle on a purple block adorned with two glitter star stickers, Moderna is on the top right on a red block, Janssen is on the bottom right on a blue block, and AstraZeneca is on the left on a red block. — Illustration: Christine Kao/STAT; Photos: Getty

It’s been four years since Covid-19 emerged, igniting a pandemic that killed millions of people and brought the world to its knees. A key factor in taming the pandemic was the creation of effective vaccines, which have saved millions of lives.

You’d think developing a successful vaccine would be an unmitigated win, from a financial perspective. And, indeed, for Pfizer and its partner BioNTech, as well as for Moderna — whose vaccines were the most widely used in the United States and much of the world — the revenues generated were absolutely staggering. But investors have shrugged at those sales as gains that will not be repeated.

Total sales of the Pfizer/BioNTech vaccine surpassed $80 billion, and more than 400 million doses of the shot and subsequent boosters have been administered in the U.S. alone. But the company’s stock price fell 32% over the past five years. Meanwhile, AstraZeneca, which told STAT it has not booked sales from its vaccine since last April and does not expect future sales, has seen its share price rise 64%. Merck, which saw its vaccine efforts fail twice, is up 56%.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Harvard's David Sinclair gets blowback over aging

WSS

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

China dismisses criticism of top diplomat's comments appearing to push for race

EU moves toward latest gene techniques in food production to counter climate change, shortages

A bus careens into a gulch in southern Mexico, leaving 27 people dead

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

explore

explore

Wikipedia

Peter Hotez and the public health issue of online harassment

Fetal cell organoids grown from amniotic fluid, study finds

As demand for Covid shots wanes, Moderna seeks its next success

$1 billion proposal to grow Boston, Massachusetts biotech

At least 13 dead in Texas as scorching temps continue

Ancient Greek ideas underpin modern concepts of pregnancy

Bright Health sells Medicare Advantage business to Molina

Former New York Mayor de Blasio and wife announce separation, but not divorce

Bright Health sells Medicare Advantage business to Molina

Former New York Mayor de Blasio and wife announce separation, but not divorce

entertainment

2 million sign

Readout Newsletter: BridgeBio, Akero, and human embryo models

Stem cell biologist probes earliest stages of human development

Lack of health data on LGBTQ+ people has serious consequences

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

Princess Kate attends Wimbledon with Roger Federer: See the photos

hotspot

knowledge

leisure time

entertainment